- In Memoriam
- Foreword to the First Edition
- Preface to the Second Edition
- Preface to the First Edition
- Contributors
- IBiological Bases of Pediatric Psychopharmacology
- 7 Neurobiology of Attention Regulation and Its Disorders
- 8 Neurobiology of Early Life Stress: Evolving Concepts
- 9 Neurobiology of Early-onset Mood Disorders
- 10 Neurobiology of Early-onset Anxiety Disorders
- 11 Neurobiology of Obsessive-Compulsive Disorder
- 12 Neurobiological Substrates of Tic Disorders
- 13 Neurobiology of Childhood Schizophrenia and Related Disorders
- 14 Neurobiology of Autism Spectrum Disorder: Implications for Improving Pharmacotherapy
- 15 Neurobiology of Aggression
- 16 Neurobiology of Eating Disorders
- 17 Neurobiology of Substance Abuse Disorders
- II Somatic Interventions
- III Assessment and Treatment
- IV Epidemiological, Research, and Methodological Considerations
- 49 Pediatric Psychopharmacoepidemiology: Who Is Prescribing? And For Whom, How, and Why?
- 50 Clinical Trials Methodology and Designs
- 51 Regulatory Issues
- 52 Ethical Issues in Pediatric Psychopharmacology
- 53 Conflict of Interest
- 54 International Patterns of Pediatric Medication for Emotional and Behavioral Disorders
- Appendix: Psychopharmacology at a Glance
- Disclosures of Financial Interests
- Index
(p. 200) Neurobiology of Autism Spectrum Disorder: Implications for Improving Pharmacotherapy
- Chapter:
- (p. 200) Neurobiology of Autism Spectrum Disorder: Implications for Improving Pharmacotherapy
- Author(s):
Alexander Westphal
and Kevin Pelphrey
- DOI:
- 10.1093/med/9780195398212.003.0014
Chapter 14 reviews recent findings from our program of functional neuroimaging research, and discuss the potential for these findings to inform and improve approaches to pharmacotherapy for individuals with autism spectrum disorder (ASD).
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- In Memoriam
- Foreword to the First Edition
- Preface to the Second Edition
- Preface to the First Edition
- Contributors
- IBiological Bases of Pediatric Psychopharmacology
- 7 Neurobiology of Attention Regulation and Its Disorders
- 8 Neurobiology of Early Life Stress: Evolving Concepts
- 9 Neurobiology of Early-onset Mood Disorders
- 10 Neurobiology of Early-onset Anxiety Disorders
- 11 Neurobiology of Obsessive-Compulsive Disorder
- 12 Neurobiological Substrates of Tic Disorders
- 13 Neurobiology of Childhood Schizophrenia and Related Disorders
- 14 Neurobiology of Autism Spectrum Disorder: Implications for Improving Pharmacotherapy
- 15 Neurobiology of Aggression
- 16 Neurobiology of Eating Disorders
- 17 Neurobiology of Substance Abuse Disorders
- II Somatic Interventions
- III Assessment and Treatment
- IV Epidemiological, Research, and Methodological Considerations
- 49 Pediatric Psychopharmacoepidemiology: Who Is Prescribing? And For Whom, How, and Why?
- 50 Clinical Trials Methodology and Designs
- 51 Regulatory Issues
- 52 Ethical Issues in Pediatric Psychopharmacology
- 53 Conflict of Interest
- 54 International Patterns of Pediatric Medication for Emotional and Behavioral Disorders
- Appendix: Psychopharmacology at a Glance
- Disclosures of Financial Interests
- Index